The Applicability of ADA, AFU, and LAC in the Early Diagnosis and Disease Risk Assessment of Hepatitis B-Associated Liver Cirrhosis and Hepatocellular Carcinoma.

Front Med (Lausanne) · 2021 · PMC8453082 · PMID 34557505

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The results revealed that ADA levels in patients with CHB, LC, and HCC were 14 U/L (11, 22), 20 U/L (17, 27), and 22 U/L (18, 29), respectively, which showed an increasing trend, and the difference was statistically significant.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.